id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-P-5687-0004,FDA,FDA-2023-P-5687,"Determination That RIOMET (Metformin Hydrochloride) Oral Solution, 500 Milligrams/5 Milliliters Has Not Been Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2025-03-13T04:00:00Z,2025,3,2025-03-13T04:00:00Z,,2025-03-13T12:52:25Z,2025-04020,0,0,09000064869e2d63
FDA-2023-P-5687-0005,FDA,FDA-2023-P-5687,"Final Response Letter from FDA CDER to Bionpharma, Inc.",Other,Denial of Petition,2025-03-13T04:00:00Z,2025,3,2025-03-13T04:00:00Z,,2025-03-13T19:27:27Z,,0,0,09000064869e77d5
FDA-2023-P-5687-0003,FDA,FDA-2023-P-5687,"Interim Response Letter from FDA CDER to Bionpharma, Inc.",Other,Response(s),2024-06-20T04:00:00Z,2024,6,2024-06-20T04:00:00Z,,2024-06-20T13:18:57Z,,0,0,09000064865c0a3b
FDA-2023-P-5687-0001,FDA,FDA-2023-P-5687,"Citizen Petition from Bionpharma, Inc.",Other,Citizen Petition,2023-12-27T05:00:00Z,2023,12,2023-12-27T05:00:00Z,,2025-03-13T18:36:06Z,,0,0,090000648635b114
FDA-2023-P-5687-0002,FDA,FDA-2023-P-5687,"Acknowledgment Letter from FDA DMS to Bionpharma, Inc.",Other,Acknowledgement Letter/Receipt,2023-12-27T05:00:00Z,2023,12,2023-12-27T05:00:00Z,,2023-12-27T12:31:11Z,,0,0,090000648635b116